Connacht Asset Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $242K | Sell |
24,155
-14,876
| -38% | -$149K | 1.43% | 42 |
|
|
2023
Q2 | $485K | Buy |
39,031
+8,062
| +26% | +$100K | 0.66% | 19 |
|
|
2023
Q1 | $434K | Buy |
30,969
+3,283
| +12% | +$46K | 0.19% | 37 |
|
|
2022
Q4 | $396K | Buy |
27,686
+15,779
| +133% | +$226K | 0.18% | 47 |
|
|
2022
Q3 | $304K | Buy |
11,907
+3,972
| +50% | +$101K | 0.22% | 58 |
|
|
2022
Q2 | $225K | Sell |
7,935
-1,760
| -18% | -$49.9K | 0.09% | 81 |
|
|
2022
Q1 | $342K | Sell |
9,695
-6,856
| -41% | -$242K | 0.18% | 70 |
|
|
2021
Q4 | $693K | Sell |
16,551
-12,018
| -42% | -$503K | 0.68% | 46 |
|
|
2021
Q3 | $1.4M | Buy |
+28,569
| New | +$1.4M | 0.91% | 24 |
|